Fresenius Group reported a third quarter net loss of 406 million euros compared to profit of 321 million euros, prior year. The company said negative result is due to the Fresenius Medical Care valuation effect according to IFRS 5 of 594 million euros. Reported loss per share was 0.72 euros compared to profit of 0.57 euros. Group net income before special items decreased by 7% or down 5% in constant currency to 344 million euros. Earnings per share before special items was 0.61 euros compared to 0.66 euros. Group EBIT before special items increased by 8% or 10% in constant currency to 519 million euros, mainly driven by the good earnings development at the Operating Companies.
from RTT - Earnings https://ift.tt/0gvB54Q
via IFTTT
No comments:
Post a Comment